Patents by Inventor Guillaume Hautbergue

Guillaume Hautbergue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of SRSF1 to treat neurodegenerative disorders
    Patent number: 10801027
    Abstract: The present disclosure relates to antagonists that target Serine/Arginine-Rich Splicing Factor 1 (SRSF1); expression vectors comprising SRSF1 antagonists; and the use of such antagonists in therapy for the treatment of neurodegenerative disorders and cancer and screening methods that identify agents that inhibit the expression or activity of SRSF1.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: October 13, 2020
    Assignee: University of Sheffield
    Inventors: Guillaume Hautbergue, Mimoun Azzouz, Alexander Whitworth, Pamela Shaw
  • INHIBITORS OF SRSF1 TO TREAT NEURODEGENERATIVE DISORDERS
    Publication number: 20190194660
    Abstract: The present disclosure relates to antagonists that target Serine/Arginine-Rich Splicing Factor 1 (SRSF1); expression vectors comprising SRSF1 antagonists; and the use of such antagonists in therapy for the treatment of neurodegenerative disorders and cancer and screening methods that identify agents that inhibit the expression or activity of SRSF1.
    Type: Application
    Filed: May 30, 2017
    Publication date: June 27, 2019
    Applicant: University of Sheffield
    Inventors: Guillaume Hautbergue, Mimoun Azzouz, Alexander Whitworth, Pamela Shaw